vs

Side-by-side financial comparison of Everest Group (EG) and IQVIA (IQV). Click either name above to swap in a different company.

Everest Group is the larger business by last-quarter revenue ($4.4B vs $4.4B, roughly 1.0× IQVIA). IQVIA runs the higher net margin — 11.8% vs 10.1%, a 1.7% gap on every dollar of revenue. On growth, IQVIA posted the faster year-over-year revenue change (10.3% vs -4.6%). Over the past eight quarters, IQVIA's revenue compounded faster (8.1% CAGR vs 3.4%).

Everest Group is a leading global reinsurance and insurance provider operating across over 100 countries. It offers diversified property, casualty, specialty, and life insurance products for commercial enterprises and individual customers, with strong risk management capabilities and long-standing industry expertise.

IQVIA Holdings, Inc., headquartered in Durham, North Carolina, is an American company focused on health information technology and clinical research.

EG vs IQV — Head-to-Head

Bigger by revenue
EG
EG
1.0× larger
EG
$4.4B
$4.4B
IQV
Growing faster (revenue YoY)
IQV
IQV
+14.9% gap
IQV
10.3%
-4.6%
EG
Higher net margin
IQV
IQV
1.7% more per $
IQV
11.8%
10.1%
EG
Faster 2-yr revenue CAGR
IQV
IQV
Annualised
IQV
8.1%
3.4%
EG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EG
EG
IQV
IQV
Revenue
$4.4B
$4.4B
Net Profit
$446.0M
$514.0M
Gross Margin
Operating Margin
12.5%
14.4%
Net Margin
10.1%
11.8%
Revenue YoY
-4.6%
10.3%
Net Profit YoY
175.2%
17.6%
EPS (diluted)
$10.71
$2.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EG
EG
IQV
IQV
Q4 25
$4.4B
$4.4B
Q3 25
$4.3B
$4.1B
Q2 25
$4.5B
$4.0B
Q1 25
$4.3B
$3.8B
Q4 24
$4.6B
$4.0B
Q3 24
$4.3B
$3.9B
Q2 24
$4.2B
$3.8B
Q1 24
$4.1B
$3.7B
Net Profit
EG
EG
IQV
IQV
Q4 25
$446.0M
$514.0M
Q3 25
$255.0M
$331.0M
Q2 25
$680.0M
$266.0M
Q1 25
$210.0M
$249.0M
Q4 24
$-593.0M
$437.0M
Q3 24
$509.0M
$285.0M
Q2 24
$724.0M
$363.0M
Q1 24
$733.0M
$288.0M
Gross Margin
EG
EG
IQV
IQV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
23.5%
Q2 24
22.6%
Q1 24
22.1%
Operating Margin
EG
EG
IQV
IQV
Q4 25
12.5%
14.4%
Q3 25
6.2%
13.5%
Q2 25
18.1%
12.6%
Q1 25
5.8%
13.0%
Q4 24
-16.1%
15.8%
Q3 24
13.5%
14.1%
Q2 24
19.7%
13.6%
Q1 24
20.1%
13.5%
Net Margin
EG
EG
IQV
IQV
Q4 25
10.1%
11.8%
Q3 25
5.9%
8.1%
Q2 25
15.1%
6.6%
Q1 25
4.9%
6.5%
Q4 24
-12.8%
11.0%
Q3 24
11.9%
7.3%
Q2 24
17.1%
9.5%
Q1 24
17.7%
7.7%
EPS (diluted)
EG
EG
IQV
IQV
Q4 25
$10.71
$2.97
Q3 25
$6.09
$1.93
Q2 25
$16.10
$1.54
Q1 25
$4.90
$1.40
Q4 24
$-13.59
$2.41
Q3 24
$11.80
$1.55
Q2 24
$16.70
$1.97
Q1 24
$16.87
$1.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EG
EG
IQV
IQV
Cash + ST InvestmentsLiquidity on hand
$2.1B
Total DebtLower is stronger
Stockholders' EquityBook value
$15.5B
$6.5B
Total Assets
$62.5B
$29.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EG
EG
IQV
IQV
Q4 25
$2.1B
Q3 25
$2.0B
Q2 25
$2.2B
Q1 25
$1.9B
Q4 24
$662.0M
$1.8B
Q3 24
$1.7B
Q2 24
$1.7B
Q1 24
$1.6B
Stockholders' Equity
EG
EG
IQV
IQV
Q4 25
$15.5B
$6.5B
Q3 25
$15.4B
$6.2B
Q2 25
$15.0B
$5.8B
Q1 25
$14.1B
$6.0B
Q4 24
$13.9B
$6.1B
Q3 24
$15.3B
$7.0B
Q2 24
$14.2B
$6.7B
Q1 24
$13.6B
$6.3B
Total Assets
EG
EG
IQV
IQV
Q4 25
$62.5B
$29.9B
Q3 25
$62.2B
$28.7B
Q2 25
$60.5B
$28.6B
Q1 25
$58.1B
$27.3B
Q4 24
$56.3B
$26.9B
Q3 24
$55.9B
$27.2B
Q2 24
$52.6B
$26.4B
Q1 24
$50.9B
$26.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EG
EG
IQV
IQV
Operating Cash FlowLast quarter
$-398.0M
$735.0M
Free Cash FlowOCF − Capex
$561.0M
FCF MarginFCF / Revenue
12.9%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
-0.89×
1.43×
TTM Free Cash FlowTrailing 4 quarters
$2.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EG
EG
IQV
IQV
Q4 25
$-398.0M
$735.0M
Q3 25
$1.5B
$908.0M
Q2 25
$1.1B
$443.0M
Q1 25
$928.0M
$568.0M
Q4 24
$780.0M
$885.0M
Q3 24
$1.7B
$721.0M
Q2 24
$1.3B
$588.0M
Q1 24
$1.1B
$522.0M
Free Cash Flow
EG
EG
IQV
IQV
Q4 25
$561.0M
Q3 25
$772.0M
Q2 25
$292.0M
Q1 25
$426.0M
Q4 24
$721.0M
Q3 24
$571.0M
Q2 24
$445.0M
Q1 24
$377.0M
FCF Margin
EG
EG
IQV
IQV
Q4 25
12.9%
Q3 25
18.8%
Q2 25
7.3%
Q1 25
11.1%
Q4 24
18.2%
Q3 24
14.7%
Q2 24
11.7%
Q1 24
10.1%
Capex Intensity
EG
EG
IQV
IQV
Q4 25
4.0%
Q3 25
3.3%
Q2 25
3.8%
Q1 25
3.7%
Q4 24
4.1%
Q3 24
3.9%
Q2 24
3.7%
Q1 24
3.9%
Cash Conversion
EG
EG
IQV
IQV
Q4 25
-0.89×
1.43×
Q3 25
5.72×
2.74×
Q2 25
1.59×
1.67×
Q1 25
4.42×
2.28×
Q4 24
2.03×
Q3 24
3.41×
2.53×
Q2 24
1.85×
1.62×
Q1 24
1.50×
1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EG
EG

Insurance$3.7B84%
Other$705.0M16%

IQV
IQV

Segment breakdown not available.

Related Comparisons